Literature DB >> 16024725

Proliferation and invasion: plasticity in tumor cells.

Chong-Feng Gao1, Qian Xie, Yan-Li Su, Julie Koeman, Sok Kean Khoo, Margaret Gustafson, Beatrice S Knudsen, Rick Hay, Nariyoshi Shinomiya, George F Vande Woude.   

Abstract

Invasive and proliferative phenotypes are fundamental components of malignant disease, yet basic questions persist about whether tumor cells can express both phenotypes simultaneously and, if so, what are their properties. Suitable in vitro models that allow characterization of cells that are purely invasive are limited because proliferation is required for cell maintenance. Here, we describe glioblastoma cells that are highly invasive in response to hepatocyte growth factor/scatter factor (HGF/SF). From this cell population, we selected subclones that were highly proliferative or displayed both invasive and proliferative phenotypes. The biological activities of invasion, migration, urokinase-type plasminogen activation, and branching morphogenesis exclusively partitioned with the highly invasive cells, whereas the highly proliferative subcloned cells uniquely displayed anchorage independent growth in soft agar and were highly tumorigenic as xenografts in immune-compromised mice. In response to HGF/SF, the highly invasive cells signal through the MAPK pathway, whereas the selection of the highly proliferative cells coselected for signaling through Myc. Moreover, in subcloned cells displaying both invasive and proliferative phenotypes, both signaling pathways are activated by HGF/SF. These results show how the mitogen-activated protein kinase and Myc pathways can cooperate to confer both invasive and proliferative phenotypes on tumor cells and provide a system for studying how transitions between invasion and proliferation can contribute to malignant progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024725      PMCID: PMC1180792          DOI: 10.1073/pnas.0504367102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Control of c-myc regulation in normal and neoplastic cells.

Authors:  C A Spencer; M Groudine
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

Review 2.  Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

Authors:  E Gherardi; M Stoker
Journal:  Cancer Cells       Date:  1991-06

3.  MET and MYC cooperate in mammary tumorigenesis.

Authors:  Alana L Welm; Suwon Kim; Bryan E Welm; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

4.  Molecular cloning and expression of human hepatocyte growth factor.

Authors:  T Nakamura; T Nishizawa; M Hagiya; T Seki; M Shimonishi; A Sugimura; K Tashiro; S Shimizu
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

5.  Met expression and sarcoma tumorigenicity.

Authors:  S Rong; M Jeffers; J H Resau; I Tsarfaty; M Oskarsson; G F Vande Woude
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

Review 6.  Tumor invasion and metastasis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

7.  Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.

Authors:  M S Pepper; K Matsumoto; T Nakamura; L Orci; R Montesano
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

8.  Evidence for the identity of human scatter factor and human hepatocyte growth factor.

Authors:  K M Weidner; N Arakaki; G Hartmann; J Vandekerckhove; S Weingart; H Rieder; C Fonatsch; H Tsubouchi; T Hishida; Y Daikuhara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

Authors:  R Montesano; K Matsumoto; T Nakamura; L Orci
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

10.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Authors:  F Bussolino; M F Di Renzo; M Ziche; E Bocchietto; M Olivero; L Naldini; G Gaudino; L Tamagnone; A Coffer; P M Comoglio
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  67 in total

1.  Blocking IKKα expression inhibits prostate cancer invasiveness.

Authors:  Rubi Mahato; Bin Qin; Kun Cheng
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

2.  Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.

Authors:  Myriem Boufraqech; Dhaval Patel; Naris Nilubol; Astin Powers; Timothy King; Jasmine Shell; Justin Lack; Lisa Zhang; Sudheer Kumar Gara; Viswanath Gunda; Joanna Klubo-Gwiezdzinska; Suresh Kumar; James Fagin; Jeffrey Knauf; Sareh Parangi; David Venzon; Martha Quezado; Electron Kebebew
Journal:  Thyroid       Date:  2018-12-28       Impact factor: 6.568

3.  Migrating with myosin VI.

Authors:  Beatrice Knudsen
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

4.  Wild type N-ras displays anti-malignant properties, in part by downregulating decorin.

Authors:  Marta Benet; Robin Yates Dulman; Raffi Suzme; Eleazar Vega-Saenz de Miera; Martha E Vega; Thuy Nguyen; Jiri Zavadil; Angel Pellicer
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Structural basis for agonism and antagonism of hepatocyte growth factor.

Authors:  W David Tolbert; Jennifer Daugherty-Holtrop; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

Authors:  Aaron P Putzke; Aviva P Ventura; Alexander M Bailey; Canan Akture; John Opoku-Ansah; Müge Celiktaş; Michael S Hwang; Douglas S Darling; Ilsa M Coleman; Peter S Nelson; Holly M Nguyen; Eva Corey; Muneesh Tewari; Colm Morrissey; Robert L Vessella; Beatrice S Knudsen
Journal:  Am J Pathol       Date:  2011-05-04       Impact factor: 4.307

7.  ETS1 regulates Twist1 transcription in a KrasG12D/Lkb1-/- metastatic lung tumor model of non-small cell lung cancer.

Authors:  Guetchyn Millien; Yuxia Cao; Carl J O'Hara; Jean-Bosco Tagne; Anne Hinds; Mary C Williams; Maria I Ramirez; Hasmeena Kathuria
Journal:  Clin Exp Metastasis       Date:  2018-06-16       Impact factor: 5.150

8.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

9.  Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102.

Authors:  Ian M Buchanan; Tamalee Scott; Anita T Tandle; William E Burgan; Teresa L Burgess; Philip J Tofilon; Kevin Camphausen
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

10.  Functional interaction between Env oncogene from Jaagsiekte sheep retrovirus and tumor suppressor Sprouty2.

Authors:  Ebenezer Chitra; Yi-Wen Lin; Fabian Davamani; Kuang-Nan Hsiao; Charles Sia; Shih-Yang Hsieh; Olivia L Wei; Jen-Hao Chen; Yen-Hung Chow
Journal:  Retrovirology       Date:  2010-08-02       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.